Healthcare - Biotechnology - NASDAQ - US
$ 7.46
-0.798 %
$ 54.4 M
Market Cap
-0.55
P/E
INCOME STATEMENT
7 M
REVENUE
-105 M
OPERATING INCOME
-102 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Kezar Life Sciences, Inc.
| Revenue | 7 M |
| Cost Of Revenue | 77.1 M |
| Gross Profit | -70.1 M |
| Operating Expenses | 111 M |
| Operating Income | -105 M |
| Other Expenses | -3.37 M |
| Net Income | -102 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 7.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 77.1 | 1.0 | 1.5 | 1.5 | 1.3 | 0.7 | 0.2 | 0.2 |
| Gross Profit | (70.1) | (1.0) | (1.5) | (1.5) | (1.3) | (0.7) | (0.2) | (0.2) |
| OPERATING INCOME | ||||||||
| Operating Expenses | 111.2 | 71.2 | 54.7 | 43.0 | 37.3 | 24.7 | 8.7 | 9.0 |
| Selling, General and Administrative Expenses | 26.5 | 20.2 | 15.7 | 12.0 | 10.0 | 6.6 | 2.3 | 1.6 |
| Research and Development Expenses | 85.7 | 51.0 | 38.9 | 31.0 | 27.4 | 18.1 | 6.5 | 7.4 |
| Operating Income | (105.2) | (71.2) | (54.7) | (43.0) | (37.3) | (24.7) | (8.7) | (9.0) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 1.6 | 1.2 | 0.2 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 3.4 | 2.9 | 29 K | 1.2 | 2.3 | 1.6 | 0.2 | 0 |
| Pre-Tax Income | (101.9) | (68.2) | (54.6) | (41.7) | (35.1) | (23.2) | (8.5) | (9.0) |
| NET INCOME | ||||||||
| Tax Provision | 0 | (2.9) | (1.4) | (2.8) | (3.6) | 1.6 | 0 | 0 |
| Net Income | (101.9) | (65.3) | (53.3) | (39.0) | (31.5) | (23.2) | (8.5) | (9.0) |
| EPS | 1.4 | 0.97 | 1.01 | 0.89 | 1.65 | 2.26 | 0.65 | 0.69 |